ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 28 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 16.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $53,000 | -48.5% | 65,000 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $103,000 | +1.0% | 65,000 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $102,000 | -28.7% | 65,000 | 0.0% | 0.00% | -50.0% |
Q1 2017 | $143,000 | +793.8% | 65,000 | +30.0% | 0.00% | – |
Q1 2016 | $16,000 | -89.4% | 50,000 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $151,000 | +24.8% | 50,000 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $121,000 | -14.2% | 50,000 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $141,000 | -15.6% | 50,000 | +167.2% | 0.00% | 0.0% |
Q1 2015 | $167,000 | -60.1% | 18,715 | -46.9% | 0.00% | -70.0% |
Q4 2014 | $419,000 | +127.7% | 35,265 | +113.1% | 0.01% | +100.0% |
Q3 2014 | $184,000 | – | 16,550 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Ventures 2007 General Partner LLC | 1,907,008 | $21,244,000 | 14.99% |
Third Rock Ventures, LLC | 4,841,591 | $53,935,000 | 6.29% |
Broadfin Capital, LLC | 857,715 | $9,555,000 | 1.00% |
NJ State Employees Deferred Compensation Plan | 25,000 | $278,000 | 0.06% |
SECTORAL ASSET MANAGEMENT INC | 112,485 | $1,253,000 | 0.05% |
C WorldWide Group Holding A/S | 100,000 | $1,161,000 | 0.02% |
Tower Research Capital LLC (TRC) | 9,921 | $111,000 | 0.01% |
SABBY MANAGEMENT, LLC | 19,997 | $223,000 | 0.01% |
Ground Swell Capital, LLC | 402 | $4,000 | 0.01% |
Point72 Asset Management, L.P. | 55,450 | $618,000 | 0.01% |